Genetic manipulation of Francisella tularensis

被引:11
|
作者
Zogaj, Xhavit [1 ]
Klose, Karl E. [1 ]
机构
[1] Univ Texas San Antonio, South Texas Ctr Emerging Infect Dis, Dept Biol, San Antonio, TX 78249 USA
来源
关键词
tularemia; transposon; allelic exchange; plasmid; targetron; select agent;
D O I
10.3389/fmicb.2010.00142
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Francisella tularensis is a facultative intracellular pathogen that causes the disease tularemia. F. tularensis subsp. tularensis causes the most severe disease in humans and has been classified as a Category A select agent and potential bioweapon. There is currently no vaccine approved for human use, making genetic manipulation of this organism critical to unraveling the genetic basis of pathogenesis and developing countermeasures against tularemia. The development of genetic techniques applicable to F. tularensis have lagged behind those routinely used for other bacteria, primarily due to lack of research and the restricted nature of the biocontainment required for studying this pathogen. However, in recent years, genetic techniques, such as transposon mutagenesis and targeted gene disruption, have been developed, that have had a dramatic impact on our understanding of the genetic basis of F. tularensis virulence. In this review, we describe some of the methods developed for genetic manipulation of F. tularensis.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Genetics and genetic manipulation in Francisella tularensis
    Frank, Dara W.
    Zahrt, Thomas C.
    [J]. FRANCISELLA TULARENSIS: BIOLOGY, PATHOGENICITY, EPIDEMIOLOGY, AND BIODEFENSE, 2007, 1105 : 67 - 97
  • [2] Genetic tools for highly pathogenic Francisella tularensis subsp tularensis
    LoVullo, Eric D.
    Sherrill, Lani A.
    Perez, Lanyn L.
    Pavelka, Martin S., Jr.
    [J]. MICROBIOLOGY-SGM, 2006, 152 : 3425 - 3435
  • [3] Molecular and genetic basis of pathogenesis in Francisella tularensis
    Barker, Jeffrey R.
    Klose, Karl E.
    [J]. FRANCISELLA TULARENSIS: BIOLOGY, PATHOGENICITY, EPIDEMIOLOGY, AND BIODEFENSE, 2007, 1105 : 138 - 159
  • [4] Francisella tularensis vaccines
    Griffin, Kate F.
    Oyston, Petra C. F.
    Titball, Richard W.
    [J]. FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY, 2007, 49 (03): : 315 - 323
  • [5] FRANCISELLA TULARENSIS - REVIEW
    Cieslik, Piotr
    Knap, Jozef
    Bielawska-Drozd, Agata
    [J]. POSTEPY MIKROBIOLOGII, 2018, 57 (01): : 58 - 67
  • [6] FRANCISELLA-TULARENSIS
    EVANS, ME
    [J]. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 1985, 6 (09): : 381 - 383
  • [7] Francisella tularensis aortitis
    Briere, M.
    Kaladji, A.
    Douane, F.
    Breux, J. P.
    Touroult-Jupin, P.
    Boisset, S.
    Edouard, S.
    Biron, C.
    Boutoille, D.
    [J]. INFECTION, 2016, 44 (02) : 263 - 265
  • [8] Francisella tularensis meningitis
    Contentin, L.
    Soret, J.
    Zamfir, O.
    Gontier, O.
    Lherm, T.
    Hamrouni, M.
    Ouchenir, A.
    Monchamps, G.
    Kalfon, P.
    [J]. MEDECINE ET MALADIES INFECTIEUSES, 2011, 41 (10): : 556 - 558
  • [9] Francisella tularensis endocarditis
    Tancik, CA
    Dillaha, JA
    [J]. CLINICAL INFECTIOUS DISEASES, 2000, 30 (02) : 399 - 400
  • [10] Francisella tularensis, Portugal
    de Carvalho, Isabel Lopes
    Escudero, Raquel
    Garcia-Amil, Cristina
    Falcao, Helena
    Anda, Pedro
    Nuncio, Maria Sofia
    [J]. EMERGING INFECTIOUS DISEASES, 2007, 13 (04) : 666 - 667